TAMOXIFEN FOR PREVENTION OF BREAST CANCER - ENCOURAGING RESULTS BUT RISKS STILL UNCLEAR (pp 813, 817) Early findings from a randomised trial investigating the effectiveness of tamoxifen to prevent breast cancer are reported in this week’s issue of THE LANCET. Although tamoxifen reduced breast cancer incidence by a third compared with women given placebo, the authors of the study caution that it is still too early to fully assess the risk to... view more... (2002-09-11)
International Study Suggests Carboplatin Could Be First-line Chemotherapy Drug For Ovarian Cancer Results of an international study in this week's issue of THE LANCET suggest that the drug carboplatin could become a first-line chemotherapeutic agent for the treatment of ovarian cancer. Carboplatin was found to be less toxic, although it had no overall survival benefit, compared with other drugs assessed in the study. Ovarian cancer is the... view more... (2002-08-14)
Urologists report success using robot-assisted surgery for urinary abnormality Ashok Hemal, M.D., a urologic surgeon from Wake Forest University Baptist Medical Center, and colleagues have reported success using robot-assisted laparoscopic surgery to repair abnormal openings between the bladder and vagina known as fistulas. view more (2008-08-19)
